Señales en vivo de MIRM | Maximiza tus Ganancias con Getagraph.com

VENDER 114312 min ago

@ $28.45

Emitido: 14 feb 2024 @ 09:30

Retorno: -9.17%

Señal anterior: feb 13 - 12:55

Señal anterior: Comprar

Retorno: -0.45 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases...

Stats
Volumen de hoy	333 209
Volumen promedio	495 320
Capitalización de mercado	1.22B
EPS	$0 ( 2024-05-02 )
Próxima fecha de ganancias	( $-0.480 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.46
ATR14	$0.0270 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-27	Bjerkholt Eric	Buy	2 000	Common Stock
2024-03-25	Radovich Peter	Sell	4 303	Common Stock
2023-01-09	Radovich Peter	Sell	1 379	Common Stock
2023-01-09	Vig Pamela	Sell	1 379	Common Stock
2019-09-10	Longpre Lara	Buy	965	Common Stock

INSIDER POWER
-83.19
Last 98 transactions
Buy: 1 143 723 \| Sell: 16 296 571

Volumen Correlación

Largo: -0.20 (neutral)

Corto: 0.49 (neutral)

Signal:(46.621) Neutral

Mirum Pharmaceuticals Inc Correlación

10 Correlaciones Más Positivas
CRGE	0.914
ZCMD	0.896
JWEL	0.887
ASPS	0.875
VMAR	0.874
CYCC	0.867
ZSAN	0.864
QLGN	0.864
AHI	0.863
ADMP	0.861

10 Correlaciones Más Negativas
KEQU	-0.895
FRG	-0.869
UEIC	-0.855
SBNY	-0.851
PTMN	-0.848
IMPP	-0.839
NESR	-0.839
RNLC	-0.838
SQFTP	-0.837
SGHT	-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mirum Pharmaceuticals Inc Correlación - Moneda/Commodity

-0.29
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.14
( neutral )

-0.44
( neutral )

-0.64
( weak negative )

Mirum Pharmaceuticals Inc Finanzas

Annual	2023
Ingresos:	$186.37M
Beneficio Bruto:	$139.01M (74.58 %)
EPS:	$-4.00

FY	2023
Ingresos:	$186.37M
Beneficio Bruto:	$139.01M (74.58 %)
EPS:	$-4.00

FY	2022
Ingresos:	$77.06M
Beneficio Bruto:	$64.69M (83.94 %)
EPS:	$-4.01

FY	2021
Ingresos:	$19.14M
Beneficio Bruto:	$17.24M (90.06 %)
EPS:	$-2.77

Financial Reports:

No articles found.

Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.